Dysregulated DcR3 expression plays an important role in tumorigenesis, metastasis and immune suppression in pancreatic head cancer [6], breast cancer [7], bladder urothelial carcinoma [8], nasopharyngeal carcinoma [9], renal carcinoma [10], glioma [11] and hepatocellular carcinoma [12, 13]. This evidence concerns the gene TNFRSF6B and nasopharyngeal carcinoma.